Email Updates

You are here

Home

2 MARCH 2018 VOLUME 19 ISSUE 9

Media Coverage

  • Differentiated care for key populations, part IV: Malawi

    The case studies presented in this four-part series come from the USAID– and PEPFAR-supported LINKAGES project in Botswana, Haiti, Kenya, and Malawi. They are examples of the out-of-facility individual model, sometimes referred to as the community model.

    March 2, 2018
    Treatment
    LINKAGES

  • In the era of daily PrEP, feds may stop research funding gels, rings, and douches for HIV prevention

    Precisely because of the overwhelming success in recent years of oral PrEP -- which various large studies have found to prevent HIV by anywhere between 90 to 100 percent -- that the future of the douche and other sorts of topically applied anti-HIV agents, such as gels and dissolvable films, all loosely termed "microbicides," is suddenly up in the air, if not outright doomed.

    March 1, 2018
    Microbicides, PrEP
    The Body

  • Intimate partner violence a major contributor to HIV epidemic among MSM in China, shows study

    HIV prevention programmes targeted at men who have sex with men (MSM) should include intimate partner violence (IPV) screening and interventions, research published in Nature Scientific Reports shows.

    February 28, 2018
    General
    aidsmap

  • Promising HIV vaccines could stall without coordinated research

    Several vaccines and drugs for preventing the spread of HIV are showing signs of success in clinical trials, three decades after scientists began the search. But some researchers fear that progress will stall without a coordinated strategy to ensure that the most promising therapies to prevent infection win support from policymakers and reach the people who need them.

    February 27, 2018
    HIV Vaccine
    Nature

  • Tweak to broadly neutralizing HIV antibody makes it last longer

    Researchers have found that a slight modification to the broadly neutralizing HIV antibody known as VRC01 lengthens its staying power in the body. This tweak could lower the cost and reduce the necessary frequency of injections of the long-acting antibody for use as HIV treatment or for prevention of the virus.

    February 27, 2018
    PrEP, Treatment
    POZ

  • Groups Working to End AIDS Fear Losing Ground Under Trump

    Advocates working to end the AIDS epidemic fear they may lose ground under the Trump administration after coming within reach of ending the disease’s siege in the US and abroad.

    February 27, 2018
    The Hill

  • Myanmar has launched a HIV/AIDS Flagship (UHF) project to be implemented in five regions and states with the highest rate of HIV infection, the official Global New Light of Myanmar reported Monday

    Myanmar has launched a HIV/AIDS Flagship (UHF) project to be implemented in five regions and states with the highest rate of HIV infection, the official Global New Light of Myanmar reported Monday.

    February 26, 2018
    General
    Xinhua

  • Most gay men ‘would disclose HIV’

    Three in five gay men in Ireland say they would tell a new partner about their HIV status. A 'Gay Community News' survey found those aged 41 and over were much less likely to talk about their HIV status than 24 to 30-year-olds. It found that many are still getting the drug PrEP, which can reduce the transmission of HIV, over the internet.

    February 26, 2018
    PrEP
    Irish Independent

  • The Trump budget's effect on HIV: Unimaginably bad

    The writers of the Trump administration’s “American Budget” for the coming fiscal year give themselves a pat on the back in advance…. Just as cutting funding for effective tuberculosis programs led to resurgent TB infections and multidrug-resistant TB, this budget… will lay the ground for increases in new HIV infections and a resurgence of HIV-related illness and death.

    February 26, 2018
    General
    Advocate

  • What are the challenges for getting gay men at risk of HIV to take PrEP?

    Professor Rusi Jaspal and Dr Jake Bayley explain their findings from conducting research into PrEP and the attitudes of gay men.

    February 26, 2018
    PrEP
    Pink News

  • 'Chipping Away' at better HIV outcomes at CROI 2018

    Improved treatment, reduction in long-term complications, and the elimination of disparities in HIV prevention and outcomes will be in the spotlight at the upcoming Conference on Retroviruses and Opportunistic Infections (CROI) 2018.

    February 26, 2018
    General
    Medscape

  • HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

    The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention, the first-ever European PrEP Summit, held in Amsterdam earlier this month, heard. Ignorance – among politicians, among healthcare workers, and among potential users of PrEP – was the main reason Europe lags far behind the USA in PrEP provision, despite there being a possibly more favourable climate in terms of potential drugs costs.

    February 25, 2018
    PrEP
    aidsmap

  • How social conservatism fueled Russia’s HIV epidemic

    At least 14,631 Russians died from AIDS-related symptoms in the first half of 2017—an increase of more than 13 percent from the year earlier. Russia now hosts the largest HIV epidemic in Eastern Europe and Central Asia, which, along with the Middle East and North Africa, make up the world’s only two regions where the rate of HIV cases is rising.

    February 25, 2018
    Treatment
    Politico Magazine

  • There's an uptick in HIV in these millennial groups. Here's why

    The Centers for Disease Control and Prevention (CDC) just released a report about HIV trends for people under 30 in the US, and the numbers show an increase in one particular group: 25- to 29-year-olds.

    February 23, 2018
    General
    Mashable

Published Research

Announcements